Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Emily Cassidy

Thoracic Surgery (Cardiothoracic Vascular Surgery) Baton Rouge, LA Medical Doctor

NPI 1548561194 CMS profile 2781267

7777 Hennessy Blvd Ste 105, Baton Rouge, LA 70808

Open in the dashboard

General payments

$1,257,737

1,692 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$72,879 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Emily Cassidy of Baton Rouge, LA is reported in the CMS Open Payments database as having received $1,257,737 across 1,692 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $72,879 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $244,888 346
2024 General $271,139 359
2023 General $330,165 366
2022 General $270,425 378
2021 General $134,965 184
2020 General $1,600 29
2019 General $4,555 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Cassidy
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Emily Cassidy were reported at $244,888. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Emily Cassidy Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,555 $886 $178–$3,167 $163
2020 $1,600 $341 $108–$1,605 $114
2021 $134,965 $453 $125–$1,886 $132
2022 $270,425 $695 $180–$2,566 $149
2023 $330,165 $745 $205–$2,662 $160
2024 $271,139 $799 $214–$2,967 $164
2025 $244,888 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $871,829 1,140 payments
  2. Zimmer Biomet Holdings, Inc. $205,128 323 payments
  3. Atricure, Inc. $73,608 52 payments
  4. Medical Device Business Services, Inc. $59,800 47 payments
  5. Ethicon US, LLC $19,899 22 payments
  6. Genentech USA, Inc. $9,712 3 payments
  7. Ethicon Inc. $6,009 4 payments
  8. Davol Inc. $3,019 39 payments
  9. Veran Medical Technologies, Inc. $2,616 8 payments
  10. AstraZeneca Pharmaceuticals LP $2,162 7 payments
  11. Other $3,956 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $500,738 242 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $259,750 118 payments
  3. Consulting Fee $233,759 111 payments
  4. Travel and Lodging $215,904 784 payments
  5. Food and Beverage $47,525 432 payments
  6. Gift $61 5 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $784,729 1,099 payments
  2. RIBFIX BLU ADVANTAGE $210,588 192 payments
  3. DA VINCI SP $87,100 41 payments
  4. AtriCure cryoICE cryoSPHERE Cryoablation System $62,298 36 payments
  5. Echelon Flex Surgery-Bariatric $34,901 23 payments
  6. ECHELON ENDOPATH $33,354 19 payments
  7. Echelon Flex Endo-Mechanical $19,801 19 payments
  8. AdvantageRib $16,081 79 payments
  9. Enseal $13,650 6 payments
  10. Echelon; Endopath $13,113 3 payments
  11. Other $36,227 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$70,429

Medicare's payments for the services billed

Medicare patients

79

Average age 72

Services billed

248

44 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
COPD 54%
Cancer 53%
Arthritis 52%
Ischemic heart disease 39%
Depression 38%
Diabetes 29%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
IMFINZI
$33 — —
KEYTRUDA
$30 — —
TALVEY
$8 — —
TECVAYLI
$8 — —
RYBREVANT
$8 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,692 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record